1. P335 Impact of cancer therapy on the course of Inflammatory Bowel Disease (ONCOEII study of GETECCU). (30th January 2023) Authors: Pérez Galindo, P; Benítez, J M; Rubín de Célix, C; Mesonero, F; Castaño García, A; García, M J; Vicuña, M; Bernal, L; Bertoletti, F; Ramírez Castro, C; Sánchez-Azofra, M; Sánchez-Delgado, L; Ponferrada, Á; Tejido Sandoval, C; Capilla, M; Laredo de la Torre, V; Diz-Lois, M T; Dueñas Sadornil, C; G... Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P545 Safety of ustekinumab in pregnant patients with inflammatory bowel disease and in their offspring: results from the DUMBO registry of GETECCU. (21st January 2022) Authors: Chaparro, M; Gutiérrez, A; Calviño-Suárez, C; Huguet, J M; Calvo, M; Aguas, M; Camargo Camero, R; de Jorge Turrión, M Á; Hervías Cruz, D; López Serrano, P; Marín Pedrosa, S; Martínez Montiel, P; Rivero, M; Vicente Lidón, R; Arias García, L; Arroyo, M; Bujanda, L; Casanova, M J; Figueiras, M; Luce... Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗